Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ · Healthcare
Ionis Pharmaceuticals, Inc. Shareholder Equity 2008–2025
Ionis Pharmaceuticals, Inc. annual shareholder equity history from 2009 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Ionis Pharmaceuticals, Inc. shareholder equity as of December 31, 2025: 489.1M, a 16.87% decrease year-over-year.
- Ionis Pharmaceuticals, Inc. shareholder equity for 2025 were 489.1M, a 16.87% decrease from 2024.
- Ionis Pharmaceuticals, Inc. shareholder equity for 2024 were 588.4M, a 52.15% increase from 2023.
- Ionis Pharmaceuticals, Inc. shareholder equity for 2023 were 386.7M, a 32.50% decrease from 2022.
- Ionis Pharmaceuticals, Inc. shareholder equity for 2022 were 572.9M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Ionis Pharmaceuticals, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $489 |
| 2024 | $588 |
| 2023 | $387 |
| 2022 | $573 |
| 2021 | $772 |
| 2020 | $743 |
| 2019 | $1,471 |
| 2018 | $1,048 |
| 2017 | $281 |
| 2016 | $100 |
| 2015 | $201 |
| 2014 | $258 |
| 2013 | $378 |
| 2012 | $183 |
| 2011 | $171 |
Ionis Pharmaceuticals, Inc. Shareholder Equity — FAQ
Ionis Pharmaceuticals, Inc. (IONS) shareholder equity over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IONS's shareholder equity history?
The chart and table above show Ionis Pharmaceuticals, Inc.'s shareholder equity by year and by quarter, including the growth rate.